Yasho Industries Limited has received a regulatory disclosure from Solidarity Advisors Private Limited regarding a significant increase in shareholding. The investment management firm, operating under its SEBI-registered Portfolio Management Services license, has acquired additional equity shares in the company through systematic open market purchases.

Shareholding Enhancement Details

Solidarity Advisors Private Limited successfully acquired 2,41,366 equity shares of Yasho Industries Limited, representing 2.00% of the company's total voting capital. This strategic acquisition has elevated the firm's total shareholding position in the company.

Transaction Methodology and Timeline

The share acquisition was executed through open market purchases spanning multiple trading sessions from January 19, 2026, to March 6, 2026. The transactions demonstrate a systematic approach to building the shareholding position over an extended period.

Key Transaction Highlights

The acquisition pattern included both purchase and minor sale transactions, with two small disposals recorded on February 25, 2026 (-2,820 shares) and February 26, 2026 (-1,524 shares), indicating active portfolio management during the accumulation period.

Company Capital Structure

Yasho Industries Limited maintains a stable equity capital structure with 1,20,57,095 equity shares of face value INR 10 each, totaling INR 12,05,70,950. The company's shares are listed on both NSE and BSE, providing liquidity for institutional investors like Solidarity Advisors.

Regulatory Compliance

The disclosure was filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, on March 9, 2026. Solidarity Advisors Private Limited confirmed that it does not belong to the promoter or promoter group of Yasho Industries Limited, maintaining its status as an independent institutional investor. The firm's Head of Compliance, Ms Naarah Myron Pereira, executed the regulatory filing within the stipulated timeframe as prescribed under SEBI (SAST) Regulations.

Yasho Industries Limited released its comprehensive investor presentation for Q3FY26 on February 12, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation provides detailed insights into the company's strong financial performance and strategic growth initiatives.

Q3FY26 Financial Highlights

The company demonstrated robust performance with consolidated revenue from operations reaching ₹20,183.03 lakhs in Q3FY26 compared to ₹14,929.66 lakhs in Q3FY25, marking a substantial 35% year-over-year growth. The quarterly performance was driven by strong volume growth of 33% and strategic product mix optimization.

Nine-Month Performance Overview

For the nine months ended December 31, 2025, the company maintained strong momentum with consolidated revenue of ₹58,376.46 lakhs, representing 19% growth from ₹49,082.62 lakhs in the corresponding previous period. EBITDA for 9MFY26 stood at ₹9,974.00 lakhs with a margin of 17.06%.

Strategic Manufacturing Project

The company announced a significant strategic manufacturing project with a large MNC, initiated in October 2025. The project involves a total cost outlay estimated between ₹85-90 crores, which will be fully funded by the customer. The company has already received an advance of ₹19.90 crores.

New R&D Facility and Manufacturing Expansion

The company's new Research & Development Centre at Pakhajan, spread over 25,000 square feet, is now fully functional with approximately 50 dedicated scientists and research personnel. The facility features modern instrumentation including AAS, CHNS Analyzer, DSC, FTIR, GC, HPLC, and UV Spectrophotometer.

Yasho Industries has deployed ₹25.9 crores towards installing two new manufacturing lines for product categories with strong growth visibility. Trial runs are expected to commence in March 2027, with commercial production planned from Q1 FY27.

Business Segment Performance

The company's diversified portfolio across five business verticals - Food Antioxidants, Aroma Chemicals, Rubber Chemicals, Lubricant Additives, and Specialty Chemicals - continues to drive growth. For Q3FY26, Industrial Chemicals contributed 85% of revenue while Consumer Chemicals accounted for 15%.

Future Growth Potential

After commissioning the two new manufacturing lines and the strategic project capex, the company expects to achieve revenue potential of ₹1,500 crores at 40% utilization of available space at Pakhajan. The facility infrastructure supports long-term growth of 15-25% annually with an expected 4:1 revenue to capex ratio for incremental investments.